• KinATLAS
  • TranscriptoNET
  • PhosphoNET
  • OncoNET
  • KinaseNET
  • DrugKiNET
  • DrugProNET
  • KiNET-AM
  • Kinetica Online

Updated November 2019

Home | Kinexus | Contact | Credits

Nomenclature

Short Name:
DCAMKL2
Full Name:
Serine-threonine-protein kinase DCAMKL2
Alias:
  • DCAK2
  • DCDC3
  • EC 2.7.11.1
  • MGC45428
  • Serine/threonine-protein kinase DCLK2
  • DCDC3B
  • DCK2
  • DCLK2
  • Doublecortin-like kinase 2

Classification

Type:
Protein-serine/threonine kinase
Group:
CAMK
Family:
DCAMKL
SubFamily:
NA
 
 

Specific Links

Entrez-Gene Entry: 166614
Entrez-Protein Entry: NP_689832
Pfam Entry: Q8N568
PhosphoNET Entry: Q8N568
Phosphosite Plus Entry: 2111
UCSD-Nature Entry: A003622
UniProt Entry: Q8N568
Kinexus Products: DCAMKL2
DCAMKLSubtide - DCAMKL2 protein kinase substrate peptide - Powder PE-01BHA90

General Links

ClustalW2
GPS-Cuckoo
Human Protein Atlas
Kinase.com
Kinase Research
Kinasource
Kinomer
Netphorest
NetworKIN
Phosida
PhosphoElm
Protein Blast
ScanSite
String

Structure

Mol. Mass (Da):
83606
# Amino Acids:
766
# mRNA Isoforms:
3
mRNA Isoforms:
85,384 Da (783 AA; Q8N568-3); 83,606 Da (766 AA; Q8N568); 83,478 Da (765 AA; Q8N568-2)
4D Structure:
Binds to and stabilizes microtubules
1D Structure:
Retrieve Gene Sequence
Retrieve Full Protein Sequence
Retrieve Catalytic Domain Sequence
 
Subfamily Alignment
subfamily domain
 
Domain Distribution:
Start End Domain
72 158 DCX
197 280 DCX
394 651 Pkinase
 

Kinexus Products

Click on entries below for direct links to relevant products from Kinexus for this protein kinase.
hiddentext
○ DCAMKLSubtide - DCAMKL2 protein kinase substrate peptide - Powder PE-01BHA90
 

Post-translation Modifications

For detailed information on phosphorylation of this kinase go to PhosphoNET
Serine phosphorylated:

S6, S93, S182, S185, S308, S312, S317, S320, S327, S337, S338, S340, S344, S347, S362, S375, S647, S682.
Threonine phosphorylated:

T61, T173, T331, T666, T685.
Tyrosine phosphorylated:

Y83, Y505.
 

Distribution

Based on gene microarray analysis from the NCBI
Human Tissue Distribution
% Max Expression:

Mean Expression:

Number of Samples:

Standard Deviation:
% Max Expression:

Mean Expression:

Number of Samples:

Standard Deviation:
  • adipose
    92

    847

    32

    1167

  • adrenal
    3

    27

    11

    35

  • bladder
    3

    28

    2

    22

  • brain
    31

    288

    99

    459

  • breast
    53

    492

    29

    370

  • cervix
    0.8

    7

    83

    8

  • colon
    0.7

    6

    34

    9

  • heart
    84

    774

    22

    642

  • intestine
    40

    364

    14

    240

  • kidney
    3

    29

    82

    44

  • liver
    3

    28

    16

    28

  • lung
    79

    724

    124

    503

  • lymphnode
    1.3

    12

    24

    15

  • ovary
    4

    36

    6

    41

  • pancreas
    8

    71

    10

    102

  • pituitary
    2

    14

    19

    20

  • prostate
    38

    350

    86

    2250

  • salivarygland
    3

    28

    6

    23

  • skeletalmuscle"
    4

    34

    86

    34

  • skin
    32

    297

    134

    297

  • spinalcord
    52

    475

    8

    842

  • spleen
    5

    42

    12

    54

  • stomach
    3

    25

    4

    24

  • testis
    3

    29

    6

    29

  • thymus
    6

    52

    8

    58

  • thyroid
    100

    921

    56

    1438

  • tonsil
    2

    15

    24

    18

  • trachea
    4

    40

    6

    34

  • uterus
    4

    40

    6

    45

  • reticulocytes"
    7

    65

    42

    50

  • t-lymphocytes
    0.7

    6

    12

    5

  • b-lymphocytes
    55

    511

    47

    644

  • neutrophils
    3

    32

    74

    206

  • macrophages
    85

    782

    78

    674

  • sperm
    4

    40

    39

    21

 

Evolution

Species Conservation
PhosphoNET % Identity:
PhosphoNET % Similarity:
Homologene %
Identity:
PhosphoNET % Identity:
PhosphoNET % Similarity:
Homologene %
Identity:
  • tableheader
    100

    100

    100
  • tableheader
    99.4

    99.4

    99.5
  • tableheader
    96.4

    97

    99
  • tableheader
    -

    -

    97
  • tableheader
    -

    -

    73
  • tableheader
    81.9

    83.9

    98
  • tableheader
    -

    -

    -
  • tableheader
    93.4

    95.4

    94
  • tableheader
    92.6

    95

    94
  • tableheader
    -

    -

    -
  • tableheader
    71

    75.7

    -
  • tableheader
    84.5

    89.9

    89
  • tableheader
    -

    -

    84
  • tableheader
    71.5

    82.4

    77
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    48
  • tableheader
    39.5

    57

    -
  • tableheader
    -

    -

    40
  • tableheader
    48.6

    62.1

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
For a wider analysis go to PhosphoNET Evolution in PhosphoNET
 

Regulation

Activation:
NA
Inhibition:
NA
Synthesis:
NA
Degradation:
NA
 

Protein Kinase Specificity

Matrix of observed frequency (%) of amino acids in aligned protein substrate phosphosites

Kinections GIF
Matrix Type:
Predicted from the application of the Kinexus Kinase Substrate Predictor Version 2.0 algorithm, which was trained with over 10,000 kinase-protein substrate pairs and 8,000 kinase-peptide substrate pairs.
Domain #:
1
 

Inhibitors

For further details on these inhibitors click on the Compound Name and enter it into DrugKiNET or click on the ID's
Based on in vitro and/or in vivo phosphorylation data
Compound Name KD, Ki or IC50 (nM) PubChem ID ChEMBL ID PubMed ID
NVP-TAE684 Kd = 16 nM 16038120 509032 22037378
Aurora A Inhibitor 23 (DF) Kd < 50 nM 21992004
Staurosporine Kd = 73 nM 5279 18183025
Aurora A Inhibitor 1 (DF) IC50 = 87.7 nM 21992004
Aurora A Inhibitor 29 (DF) Kd < 100 nM 21992004
XMD8-92 IC50 = 190 nM 46843772 1673046 20832753
Cdk1/2 Inhibitor III IC50 > 250 nM 5330812 261720 22037377
Crizotinib Kd = 370 nM 11626560 601719 22037378
Ruxolitinib Kd = 760 nM 25126798 1789941 22037378
TG101348 Kd = 870 nM 16722836 1287853 22037378
PHA-665752 Kd = 990 nM 10461815 450786 22037378
AC1NS7CD Kd = 1 µM 5329665 295136 22037378
BCP9000906 IC50 > 1 µM 5494425 21156 22037377
MK5108 IC50 > 1 µM 24748204 20053775
SNS032 Kd = 1 µM 3025986 296468 18183025
WZ3146 Kd > 1 µM 44607360 20033049
WZ4002 Kd > 1 µM 44607530 20033049
Momelotinib IC50 > 2 µM 25062766 19295546
AT7519 Kd = 2.6 µM 11338033 22037378
Sunitinib Kd = 2.7 µM 5329102 535 18183025
SU14813 Kd = 3.7 µM 10138259 1721885 22037378
JNJ-7706621 Kd = 4.5 µM 5330790 191003 18183025
Lestaurtinib Kd = 4.5 µM 126565 22037378
 

Disease Linkage

Gene Expression in Cancers:

The COSMIC website notes an up-regulated expression score for DCAMKL2 in diverse human cancers of 390, which is 0.8-fold of the average score of 462 for the human protein kinases. The down-regulated expression score of 4 for this protein kinase in human cancers was 0.1-fold of the average score of 60 for the human protein kinases.
Mutagenesis Experiments:

Insertional mutagenesis studies in mice have not yet revealed a role for this protein kinase in mouse cancer oncogenesis.
Mutation Rate in All Cancers:

Percent mutation rates per 100 amino acids length in human cancers: 0.08 % in 24690 diverse cancer specimens. This rate is very similar (+ 6% higher) to the average rate of 0.075 % calculated for human protein kinases in general.
Mutation Rate in Specific Cancers:

Highest percent mutation rates per 100 amino acids length in human cancers: 0.38 % in 1259 large intestine cancers tested; 0.35 % in 603 endometrium cancers tested; 0.3 % in 864 skin cancers tested; 0.27 % in 575 stomach cancers tested; 0.17 % in 548 urinary tract cancers tested; 0.15 % in 710 oesophagus cancers tested.
Frequency of Mutated Sites:

Most frequent mutations with the number of reports indicated in brackets: R275C (5); E594G (4).
Comments:
Only 3 deletions, 1 insertion, and no complex mutations are noted on the COSMIC website.
 
COSMIC Entry:
DCLK2
OMIM Entry:
613166
  • Home
  • Top of Page
Copyright 2019 Kinexus BioInformatics Corporation